Anteris Technologies Global Corp (AVR)

$5.58 +0.05 (0.90%)
Market Cap 537.69M
Revenue (ttm) 1.91M
Net Income (ttm) -94.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,928.80%
Debt to Equity Ratio -0.16
Volume 663,500
Avg Vol 892,170
Day's Range N/A - N/A
Shares Out 97.23M
Stochastic %K 16%
Beta 1.58
Analysts Strong Sell
Price Target $15.60

Company Profile

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into dura...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 61 7 3152 3200
Address:
Toowong Tower, Level 3, Suite 302 9 Sherwood Road, Toowong, Australia
cubie
cubie Apr. 10 at 11:23 PM
$AVR $MDT :plenty of potential" huh? u suck dawg, just admit it😂😆 yes cubie did learn something, ur not very good 😆 $REPL
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 7 at 10:23 PM
$AVR RSI: 36.95, MACD: -0.1976 Vol: 0.48, MA20: 5.72, MA50: 5.89 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
KylaGPS10x
KylaGPS10x Apr. 3 at 4:34 PM
$AVR hmmm nice after hours move let’s hope it sticks
0 · Reply
erevnon
erevnon Mar. 12 at 5:35 PM
Cantor Fitzgerald assumes Anteris Technologies Glb $AVR at Overweight rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Namis
Namis Mar. 9 at 2:01 PM
$AVR new position
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 24 at 9:34 PM
$AVR RSI: 56.31, MACD: 0.1370 Vol: 0.31, MA20: 5.84, MA50: 5.45 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
NeonRSI_404
NeonRSI_404 Feb. 24 at 6:48 PM
$AVR low liquidity name quiet accumulation possible if it keeps holding support
0 · Reply
topstockalerts
topstockalerts Feb. 23 at 6:28 PM
$AVR Curling back up with buyers stepping in 📈. Momentum is building and price is starting to respond. This could be the start of another move.
0 · Reply
Polfarer123
Polfarer123 Feb. 20 at 5:58 PM
$AVR new data published but nothing is happening with the stock price ??
0 · Reply
MaryLacy202
MaryLacy202 Feb. 11 at 3:38 PM
$AVR Anteris or unknown; if Anteris Technologies, structural heart medtech; early-stage, high-risk; competes with Edwards, Medtronic.
1 · Reply
Latest News on AVR
Anteris Technologies (AVR) Receives Overweight Rating from Cantor Fitzgerald | AVR Stock News

2026-03-12T16:03:29.000Z - 6 weeks ago

Anteris Technologies (AVR) Receives Overweight Rating from Cantor Fitzgerald | AVR Stock News

Anteris Technologies Global Corp at Barclays Global Healthcare Conference Transcript

2026-03-11T00:00:26.000Z - 6 weeks ago

Anteris Technologies Global Corp at Barclays Global Healthcare Conference Transcript

Anteris Reports 2025 Financial Results and Provides Corporate Update

Thu, 26 Feb 2026 18:00:00 -0500 - 2 months ago

Anteris Reports 2025 Financial Results and Provides Corporate Update

Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises

Jan 22, 2026, 4:02 PM EST - 3 months ago

Anteris Announces Strategic Investment from Medtronic to Continue Advancing TAVR in $320 Million Aggregate Capital Raises

Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock

Jan 22, 2026, 4:01 PM EST - 3 months ago

Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock

Anteris Technologies Surges On Pricing Of $200Mln Public Offering

2026-01-21T10:29:11.000Z - 3 months ago

Anteris Technologies Surges On Pricing Of $200Mln Public Offering

What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours?

2026-01-21T06:38:18.000Z - 3 months ago

What Sparked Anteris Technologies (AVR) Stock Surge Over 52% After-Hours?

Anteris Prices $200 Mln Public Offering; Announces Medtronic Private Placement Up To $90 Mln

2026-01-21T06:13:09.000Z - 3 months ago

Anteris Prices $200 Mln Public Offering; Announces Medtronic Private Placement Up To $90 Mln

Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering

Jan 20, 2026, 10:53 PM EST - 3 months ago

Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering

Anteris Technologies (AVR) Reports Promising Results for DurAVR THV in Aortic Stenosis

2025-11-17T11:34:16.000Z - 5 months ago

Anteris Technologies (AVR) Reports Promising Results for DurAVR THV in Aortic Stenosis

Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves

Nov 17, 2025, 6:00 AM EST - 5 months ago

Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves

Sio Capital Management, LLC Reduces Stake in Anteris Technologies Global Corp

2025-11-15T01:52:35.000Z - 5 months ago

Sio Capital Management, LLC Reduces Stake in Anteris Technologies Global Corp

Anteris Announces Results for the Third Quarter of 2025

Nov 12, 2025, 5:52 PM EST - 5 months ago

Anteris Announces Results for the Third Quarter of 2025

Anteris Technologies (AVR) Reports Promising One-Year Results for DurAVR Heart Valve

2025-10-28T23:51:59.000Z - 6 months ago

Anteris Technologies (AVR) Reports Promising One-Year Results for DurAVR Heart Valve

Anteris Technologies (AVR) Advances DurAVR Heart Valve Trial

2025-10-27T23:25:52.000Z - 6 months ago

Anteris Technologies (AVR) Advances DurAVR Heart Valve Trial

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

Oct 27, 2025, 5:43 PM EDT - 6 months ago

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

Anteris Technologies (AVR) to Present Key Clinical Outcomes at TCT 2025

2025-10-27T14:27:10.000Z - 6 months ago

Anteris Technologies (AVR) to Present Key Clinical Outcomes at TCT 2025

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025

Oct 27, 2025, 8:43 AM EDT - 6 months ago

Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025

L1-backed heart medtech Anteris Technologies rakes in $39m

2025-10-26T06:38:13.000Z - 6 months ago

L1-backed heart medtech Anteris Technologies rakes in $39m

Anteris Technologies (AVR) Gains Approval for Global Heart Valve Trial in Denmark

2025-10-15T14:57:36.000Z - 6 months ago

Anteris Technologies (AVR) Gains Approval for Global Heart Valve Trial in Denmark

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders

Sep 19, 2025, 2:30 AM EDT - 7 months ago

Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders

Anteris Technologies (AVR) Reschedules Special Stockholders Meeting

2025-09-11T14:26:24.000Z - 8 months ago

Anteris Technologies (AVR) Reschedules Special Stockholders Meeting

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders

Sep 11, 2025, 8:50 AM EDT - 8 months ago

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders

Anteris Announces Results for the Second Quarter of 2025

Aug 11, 2025, 4:52 PM EDT - 9 months ago

Anteris Announces Results for the Second Quarter of 2025

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

Jun 9, 2025, 10:52 PM EDT - 11 months ago

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

Mon, 31 Mar 2025 07:15:00 -0400 - 1 year ago

Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV

Anteris Reports One-Year Patient Outcomes for DurAVR® THV

Fri, 21 Mar 2025 07:30:00 -0400 - 1 year ago

Anteris Reports One-Year Patient Outcomes for DurAVR® THV

Anteris Reports 2024 Financial Results and Provides Corporate Update

Wed, 12 Mar 2025 20:33:00 -0400 - 1 year ago

Anteris Reports 2024 Financial Results and Provides Corporate Update

Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast

2025-02-18T14:30:15.000Z - 1 year ago

Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast

Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst

2025-01-07T19:45:28.000Z - 1 year ago

Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

Mon, 16 Dec 2024 19:49:00 -0500 - 1 year ago

Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering

Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering

Thu, 12 Dec 2024 22:34:00 -0500 - 1 year ago

Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering

Anteris Technologies (AVR) Plans $100 Million IPO on Nasdaq

2024-12-10T08:50:33.000Z - 1 year ago

Anteris Technologies (AVR) Plans $100 Million IPO on Nasdaq

Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering

Mon, 09 Dec 2024 07:43:00 -0500 - 1 year ago

Anteris Technologies Global Corp. Announces Launch of U.S. Initial Public Offering

Anteris Technologies Global Corp. Files Registration Statement for Proposed US Initial Public Offering

Sun, 24 Nov 2024 21:08:00 -0500 - 1 year ago

Anteris Technologies Global Corp. Files Registration Statement for Proposed US Initial Public Offering

Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip™ Passes Animal Study

Mon, 01 Jul 2024 05:30:00 -0400 - 1 year ago

Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip™ Passes Animal Study

DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case

Mon, 14 Aug 2023 06:00:00 -0400 - 2 years ago

DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case

Anteris Technologies Commences American Depository Receipt Program

Wed, 09 Aug 2023 06:30:00 -0400 - 2 years ago

Anteris Technologies Commences American Depository Receipt Program

Anteris Technologies Commences US Early Feasibility Study

Wed, 09 Aug 2023 06:00:00 -0400 - 2 years ago

Anteris Technologies Commences US Early Feasibility Study

cubie
cubie Apr. 10 at 11:23 PM
$AVR $MDT :plenty of potential" huh? u suck dawg, just admit it😂😆 yes cubie did learn something, ur not very good 😆 $REPL
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 7 at 10:23 PM
$AVR RSI: 36.95, MACD: -0.1976 Vol: 0.48, MA20: 5.72, MA50: 5.89 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
KylaGPS10x
KylaGPS10x Apr. 3 at 4:34 PM
$AVR hmmm nice after hours move let’s hope it sticks
0 · Reply
erevnon
erevnon Mar. 12 at 5:35 PM
Cantor Fitzgerald assumes Anteris Technologies Glb $AVR at Overweight rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
Namis
Namis Mar. 9 at 2:01 PM
$AVR new position
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 24 at 9:34 PM
$AVR RSI: 56.31, MACD: 0.1370 Vol: 0.31, MA20: 5.84, MA50: 5.45 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
NeonRSI_404
NeonRSI_404 Feb. 24 at 6:48 PM
$AVR low liquidity name quiet accumulation possible if it keeps holding support
0 · Reply
topstockalerts
topstockalerts Feb. 23 at 6:28 PM
$AVR Curling back up with buyers stepping in 📈. Momentum is building and price is starting to respond. This could be the start of another move.
0 · Reply
Polfarer123
Polfarer123 Feb. 20 at 5:58 PM
$AVR new data published but nothing is happening with the stock price ??
0 · Reply
MaryLacy202
MaryLacy202 Feb. 11 at 3:38 PM
$AVR Anteris or unknown; if Anteris Technologies, structural heart medtech; early-stage, high-risk; competes with Edwards, Medtronic.
1 · Reply
twixbarrtwits
twixbarrtwits Feb. 11 at 12:38 PM
$AVR 5.82
0 · Reply
AZOZ
AZOZ Feb. 10 at 1:46 PM
$AVR Insider activity!
0 · Reply
AlertsAndNews
AlertsAndNews Feb. 10 at 3:42 AM
$AVR quite the 10%+ buy here L1 Capital Pty Ltd (10%+) purchased 6,333,334 shares at an average price of $5.58 (Form 4).
0 · Reply
FilingTracker
FilingTracker Feb. 10 at 1:53 AM
$AVR Massive $28.75 million purchase by 10% owner: https://www.sec.gov/Archives/edgar/data/1817646/000107997326000185/xslF345X05/ownership.xml
1 · Reply
PowerPlayerPro
PowerPlayerPro Feb. 4 at 4:01 PM
$AVR is a REIT focused on healthcare properties (AvalonBay Communities) or a technology company; without specifics, its performance would depend on its business model.
0 · Reply
NVDAMillionaire
NVDAMillionaire Feb. 4 at 3:40 PM
$AVR Really good write-up that perfectly summarizes AVR's present situation. So if you want to bring your AVR knowledge up to date or just discover AVR, this is required reading. https://everyticker.com/quote/AVR/analysis/anteris-technologies-betting-on-biomimetic-innovation-in-the-structural-heart-market-avr
0 · Reply
michaelburryburner
michaelburryburner Feb. 3 at 5:58 PM
$AVR and now the waiting game…
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 3 at 4:09 AM
$AVR RSI: 76.32, MACD: 0.3826 Vol: 0.79, MA20: 5.48, MA50: 4.99 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
OGLars
OGLars Jan. 29 at 3:52 PM
$AVR whats going on here??? Coming back down..?? Where's the entry point
0 · Reply
StockOrTwist
StockOrTwist Jan. 27 at 1:01 PM
$AVR https://www.youtube.com/watch?v=v87kP2BSzeM&list=PLG-rFJE9CyVVwaGfeaM4aC1Sg1pegeEeQ&index=15&pp=gAQBiAQB0gcJCXwKAYcqIYzvsAgC
0 · Reply
rangervs
rangervs Jan. 26 at 7:51 PM
$GLSI keep adding pressure cooker $AMIX near 52 week low worth taking a position $AVR $7+ would be nice
0 · Reply
StockOrTwist
StockOrTwist Jan. 26 at 2:13 PM
$AVR https://www.youtube.com/watch?v=v87kP2BSzeM&list=PLG-rFJE9CyVVwaGfeaM4aC1Sg1pegeEeQ&index=12&pp=iAQB
0 · Reply